Secretory leukocyte protease inhibitor interferes with uptake of lipopolysaccharide by macrophages

Citation
A. Ding et al., Secretory leukocyte protease inhibitor interferes with uptake of lipopolysaccharide by macrophages, INFEC IMMUN, 67(9), 1999, pp. 4485-4489
Citations number
42
Categorie Soggetti
Immunology
Journal title
INFECTION AND IMMUNITY
ISSN journal
00199567 → ACNP
Volume
67
Issue
9
Year of publication
1999
Pages
4485 - 4489
Database
ISI
SICI code
0019-9567(199909)67:9<4485:SLPIIW>2.0.ZU;2-4
Abstract
Macrophages are among the most sensitive targets of bacterial endotoxin (LP S), responding to minute amounts of LPS by releasing a battery of inflammat ory mediators. Transfection of macrophages with secretory leukocyte proteas e inhibitor (SLPI) renders these cells refractory to LPS stimulation. Here we show that uptake of LPS from soluble CD14 (sCD14)-LPS complexes by SLPI- overexpressing cells was only 50% of that seen in control cells. SLPI trans fectants and mock transfectants did not differ in the surface expression of CD14 or CD18, We show, in addition, that recombinant human SLPI can bind t o purified endotoxin in vitro, SLPI caused a decrease in the binding of LPS to sCD14 as assessed both by fluorescence quenching of labeled LPS and by nondenaturing polyacrylamide gel electrophoresis, These results suggest tha t the inhibitory effect of SLPI on macrophage responses to LPS may, in part , be due to its blockade of LPS transfer to soluble CD14 and its interferen ce with uptake of LPS from LPS-sCD14 complexes by macrophages.